Risklick
1 known investors
RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines. The platform serves pharmaceutical companies and clinical research organizations seeking to reduce time to market and improve protocol quality.
Founders & leadership
S
Sven
B
Beat
I
IngridPhysician
Board
ME
Matthias EggerProfessor of Epidemiology
Investors Β· 1
Frequently asked questions
- What does Risklick do?
- RiskLick develops Protocol AI, an AI-powered software platform for designing and developing clinical trial protocols and study plans to accelerate drug development timelines. The platform serves pharmaceutical companies and clinical research organizations seeking to reduce time to market and improve protocol quality.
- Who are Risklick's investors?
- Risklick's investors include Debiopharm Innovation Fund.